Moreover, the fasting serum insulin level was increased after chemerin treatment or Ucp1 gene ablation (Fig. 3k), even though the homeostasis model assessment of insulin resistance (HOMA-IR) showed a modest increase without a statistical difference (Fig. 3l). The gene discussed is RARRES2; the disease is Insulin resistance.